Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen's Type-it PCR-based Kits

Qiagen announced this week it was launching three new kits on its PCR-based Type-it product line. The newly launched kits — the Type-it Fast SNP Probe PCR Kit, the Type-it Microsatellite PCR Kit, and the Type-it Mutation Detect PCR Kit — allow for the genotyping of SNPs, microsatellites and mutations for cancer and disease research, animal breeding, and biomarker discovery.
The Type-it Microsatellite PCR Kit is a multiplex PCR-based kit for the detection of microsatellite loci in humans, animals, plants and bacteria using any detection platform. The kit allows coamplification of all fragments without the need for optimization of PCR parameters. “[It] can be effectively used in challenging settings such as capillary sequencers,” Qiagen said in a statement.
The Type it Mutation Detect PCR Kit is for the detection of mutations such as deletions and translocations or for preamplification of SNPs using multiplex PCR technology. “Multiple mutation targets are amplified in parallel using one protocol,” the company said. 

The Type it Fast SNP Probe PCR Kit enables SNP genotyping using 5’-nuclease assays. Qiagen said that the product offers high call rates when targeting difficult SNP loci or when using low template amounts, time savings of up to 40 percent compared to conventional methods, and rapid ramping rates.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.